Pharma's Consolidation Creates New Kind of Player.(Statistical Data Included)

Chemical Market Reporter, May, 2000 by MIRASOL, FELIZA

Companies become broader and more efficient. THE RECENT merger and acquisition activity in the drug industry is changing the landscape of pharmaceutical players. Within just the past two years, consolidation has created a new breed of super drug companies, driving a major shift in company rankings.

"Merger and acquisition has been an important method of generating growth for companies in all industries, but in the pharmaceutical industry in the late-1990s, it began to enter a different league from previous transactions. Companies are being created with a greater dominance of the market than has previously been seen," the New York-based consultancy, Datamonitor, says in a newly published report on M&A portfolio synergies. Glaxo SmithKline, the...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here